Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891027494> ?p ?o ?g. }
- W2891027494 abstract "Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Several clinical phenotypes have been described, but subepidermal blistering is characteristic of all variants. Limited data on clinical and immunopathological characteristics and treatment outcomes in EBA are available. To fill this gap, we collected this information from EBA cases, meeting current diagnostic criteria, published between 1971 and 2016. We identified 1159 EBA cases. This number must be, however, interpreted with caution, as it is not possible to check for multiple reporting. The analysis of all cases indicated that EBA affects all age groups (median: 50 years, range: 1 to 94 years) at an equal gender distribution. Non-mechanobullous (non-MB) forms of EBA were observed in 55% of patients, whereas the mechanobullous variant (MB-EBA) or a combination of both variants was described in 38 or 7% of patients, respectively. Type VII collagen (COL7)-specific autoantibodies were primarily of the IgG isotype, but anti-COL7 IgA, IgM and IgE were also documented. Comparison of the 2 clinical EBA types showed a higher frequency of IgA deposits in non-MB EBA as opposed to MB EBA. Mucous membrane involvement was observed in 23% of patients, and 4.4% of cases were associated with other chronic inflammatory diseases. Of note, IgA deposits were more frequently observed in cases with mucous membrane involvement. Our analysis indicated that EBA is difficult to treat and that the choice of treatment varies widely. Chi square was applied to identify medications associated with complete remission (CR). Considering all EBA cases, intravenous immunoglobulin (IVIG, p = 0.0047) and rituximab (p = 0.0114) were associated with CR. Subgroup analysis demonstrated that no treatment was associated with CR for non-MB EBA, while IVIG (p = 0.003) was associated with CR in MB EBA. Within the limitations of the study, we here document the clinical and immunopathological characteristics and treatment outcomes in a large cohort of EBA patients. The observed associations of single drugs with treatment outcome may serve as a guide to develop clinical trials." @default.
- W2891027494 created "2018-09-27" @default.
- W2891027494 creator A5008159107 @default.
- W2891027494 creator A5021559096 @default.
- W2891027494 creator A5042251985 @default.
- W2891027494 creator A5043316836 @default.
- W2891027494 creator A5045431309 @default.
- W2891027494 creator A5050422951 @default.
- W2891027494 creator A5077174818 @default.
- W2891027494 creator A5080015762 @default.
- W2891027494 creator A5090549024 @default.
- W2891027494 date "2018-09-04" @default.
- W2891027494 modified "2023-10-18" @default.
- W2891027494 title "Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients" @default.
- W2891027494 cites W149106641 @default.
- W2891027494 cites W1541570388 @default.
- W2891027494 cites W1873670570 @default.
- W2891027494 cites W1887289690 @default.
- W2891027494 cites W1967191140 @default.
- W2891027494 cites W1971477992 @default.
- W2891027494 cites W1971831505 @default.
- W2891027494 cites W1976058657 @default.
- W2891027494 cites W1976101571 @default.
- W2891027494 cites W1979133237 @default.
- W2891027494 cites W1980761580 @default.
- W2891027494 cites W1984010794 @default.
- W2891027494 cites W1985031981 @default.
- W2891027494 cites W1991110217 @default.
- W2891027494 cites W1994530357 @default.
- W2891027494 cites W1994857729 @default.
- W2891027494 cites W1994992738 @default.
- W2891027494 cites W1996425946 @default.
- W2891027494 cites W1999905091 @default.
- W2891027494 cites W2004474855 @default.
- W2891027494 cites W2017875704 @default.
- W2891027494 cites W2018767010 @default.
- W2891027494 cites W2019678455 @default.
- W2891027494 cites W2021988356 @default.
- W2891027494 cites W2025947395 @default.
- W2891027494 cites W2031857913 @default.
- W2891027494 cites W2056653026 @default.
- W2891027494 cites W2062907320 @default.
- W2891027494 cites W2065955353 @default.
- W2891027494 cites W2067549990 @default.
- W2891027494 cites W2068021720 @default.
- W2891027494 cites W2071668217 @default.
- W2891027494 cites W2078618974 @default.
- W2891027494 cites W2079464368 @default.
- W2891027494 cites W2082579662 @default.
- W2891027494 cites W2084180208 @default.
- W2891027494 cites W2085701061 @default.
- W2891027494 cites W2087323512 @default.
- W2891027494 cites W2094487977 @default.
- W2891027494 cites W2098502510 @default.
- W2891027494 cites W2121837835 @default.
- W2891027494 cites W2130950786 @default.
- W2891027494 cites W2139860679 @default.
- W2891027494 cites W2142275262 @default.
- W2891027494 cites W2142981571 @default.
- W2891027494 cites W2144616572 @default.
- W2891027494 cites W2151131964 @default.
- W2891027494 cites W2156974701 @default.
- W2891027494 cites W2167761151 @default.
- W2891027494 cites W2183410468 @default.
- W2891027494 cites W2228797053 @default.
- W2891027494 cites W2290793746 @default.
- W2891027494 cites W2298164422 @default.
- W2891027494 cites W2313057060 @default.
- W2891027494 cites W2313977109 @default.
- W2891027494 cites W2325408260 @default.
- W2891027494 cites W2406321286 @default.
- W2891027494 cites W2408929256 @default.
- W2891027494 cites W2411476402 @default.
- W2891027494 cites W2509977077 @default.
- W2891027494 cites W2522529781 @default.
- W2891027494 cites W2592481086 @default.
- W2891027494 cites W2605578593 @default.
- W2891027494 cites W2617402993 @default.
- W2891027494 cites W2748978776 @default.
- W2891027494 cites W2769095837 @default.
- W2891027494 cites W2789239266 @default.
- W2891027494 cites W3021825977 @default.
- W2891027494 cites W39351818 @default.
- W2891027494 cites W4211003831 @default.
- W2891027494 cites W4229908854 @default.
- W2891027494 cites W4231717299 @default.
- W2891027494 cites W4235715233 @default.
- W2891027494 cites W4242104122 @default.
- W2891027494 cites W4248089600 @default.
- W2891027494 cites W4297934026 @default.
- W2891027494 cites W4298220258 @default.
- W2891027494 cites W4300192807 @default.
- W2891027494 cites W57375938 @default.
- W2891027494 doi "https://doi.org/10.1186/s13023-018-0896-1" @default.
- W2891027494 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6122731" @default.
- W2891027494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30180870" @default.
- W2891027494 hasPublicationYear "2018" @default.
- W2891027494 type Work @default.
- W2891027494 sameAs 2891027494 @default.
- W2891027494 citedByCount "54" @default.